YD Bio Limited Ordinary Shares
YDES · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $41 | $41 | $49 | $49 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $41 | $41 | $48 | $49 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$3 | $0 | $2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$3 | $0 | $2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.65 | -0.98 | 0.1 | 0.54 |
| % Growth | 33.7% | -1,080% | -81.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |